• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Analysis of clinical manifestations of hospitalized children infected with seasonal influenza A virus and 2009 novel influenza A (H1N1) virus in Beiji

tetano

Editor, Senior Moderator
Zhonghua Er Ke Za Zhi. 2011 Jul;49(7):539-544.
[Analysis of clinical manifestations of hospitalized children infected with seasonal influenza A virus and 2009 novel influenza A (H1N1) virus in Beijing.]
[Article in Chinese]
Sha L, Zhu RN, Cao L, Yuan Y, Li Y, Qu D, Wang F, Sun Y, Deng J, Zhao LQ, Qian Y, Ren XX, DU JB.
Source

Department of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Abstract
OBJECTIVE:

The novel influenza A (H1N1) virus firstly detected in April 2009 in Mexico rapidly spread to many countries including the United States and Canada where humans were infected with the H1N1 virus and deaths were reported. The pandemic virus strain had never been detected in specimen of human beings and swine. It was so highly contagious and widely spread that threatened life of humans globally. This study aimed to analyze clinical data of hospitalized children patients with 2009 novel H1N1 influenza A virus infection confirmed by etiologic tests, and compared with that of seasonal influenza A.
METHOD:

Clinical manifestations, laboratory and therapy data from the hospitalized children were collected by designed case report form and analyzed. All patients were enrolled from Capital Institute of Pediatrics from January 2003 to 2010. There were 152 cases in seasonal influenza A group, which was composed of 100 boys and 52 girls. Other 93 boys and 86 girls formed 2009 novel influenza A group.
RESULT:

Influenza A was dominate from 2003 to 2008 and the peak season was December and January, while the peak hospitalized time of 2009 novel H1N1 influenza was from November 2009 to January 2010. The median age of seasonal influenza group was 35 months, which was lower than that of novel influenza group (Z = -6.702, P < 0.01). Besides, 80.9% of the patients in seasonal influenza group were infants, while the novel influenza A group was mainly composed of infants and pre-school children (χ(2) = 40.725, P < 0.01). The cases of both groups had influenza-like symptoms at onset and the most common presentations were fever and cough. The duration of fever was much longer in 2009 novel influenza group (Z = -7.173, P < 0.01). Patients in two groups nearly had the same symptoms except cough was more frequently presented by novel influenza A group cases (χ(2) = 4.109, P < 0.05). In laboratory examination, the novel influenza group had more cases with abnormality in blood platelet, CRP, ALT, and CK-MB than that of seasonal influenza group (χ(2) = 7.562, 17.245, 4.398, 6.217, P < 0.01). Patients in novel influenza A group had more changes in electrocardiogram(χ(2) = 24.461, P < 0.01). More patients had common underlying medical condition in novel influenza groups than those in seasonal influenza group (χ(2) = 12.553, P < 0.01). Furthermore, the groups had different age distribution in underlying medical diseases (χ(2) = 7.231, P < 0.05). Children with 2009 novel H1N1 virus infection tended to catch pneumonia (χ(2) = 8.661, P < 0.01) and became the severe cases (χ(2) = 10.595, P < 0.01). They had much higher ICU admission rate (χ(2) = 12.873, P < 0.01) and longer hospital stay (Z = -2.764, P < 0.01).
CONCLUSION:

As a new variant of influenza virus A, 2009 novel H1N1 influenza A had stronger pathogenicity. Children with underlying medical conditions had the high risk to be infected and developed severe manifestations.

PMID:
22088186
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/22088186
 
Back
Top Bottom